118 related articles for article (PubMed ID: 2308239)
21. L-dopaergic components in the caudal ventrolateral medulla in baroreflex neurotransmission.
Miyamae T; Goshima Y; Yue JL; Misu Y
Neuroscience; 1999; 92(1):137-49. PubMed ID: 10392837
[TBL] [Abstract][Full Text] [Related]
22. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
Williamson KL; Broadley KJ
Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
[TBL] [Abstract][Full Text] [Related]
23. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
[TBL] [Abstract][Full Text] [Related]
24. Presynaptic mediation by alpha 2-, beta 1- and beta 2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus.
Ueda H; Goshima Y; Misu Y
Life Sci; 1983 Jul; 33(4):371-6. PubMed ID: 6135966
[TBL] [Abstract][Full Text] [Related]
25. Effects of indomethacin on muscarinic inhibition of endogenous noradrenaline release from rat isolated trachea.
Racké K; Brunn G; Elsner M; Wessler I
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):21-7. PubMed ID: 8377837
[TBL] [Abstract][Full Text] [Related]
26. Evidence for L-dopa systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat.
Kubo T; Yue JL; Goshima Y; Nakamura S; Misu Y
Neurosci Lett; 1992 Jun; 140(2):153-6. PubMed ID: 1501771
[TBL] [Abstract][Full Text] [Related]
27. Mass spectrometric measurement of catecholamine turnover in rat hypothalamus after long-term L-dopa infusion.
Freed CR; Murphy RC
J Pharmacol Exp Ther; 1978 Jun; 205(3):702-9. PubMed ID: 660538
[TBL] [Abstract][Full Text] [Related]
28. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
Misu Y; Goshima Y; Ueda H; Kubo T
J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
[TBL] [Abstract][Full Text] [Related]
29. L-DOPA induces concentration-dependent facilitation and inhibition of presynaptic acetylcholine release in the guinea-pig submucous plexus.
Hirai K; Katayama Y; Misu Y
Brain Res; 1996 Apr; 718(1-2):105-11. PubMed ID: 8773771
[TBL] [Abstract][Full Text] [Related]
30. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats.
Yue JL; Okamura H; Goshima Y; Nakamura S; Geffard M; Misu Y
Neuroscience; 1994 Sep; 62(1):145-61. PubMed ID: 7816196
[TBL] [Abstract][Full Text] [Related]
31. Neurotensin-induced release of endogenous noradrenaline from rat hypothalamic slices.
Okuma Y; Osumi Y
Life Sci; 1982 Jan; 30(1):77-84. PubMed ID: 7054638
[TBL] [Abstract][Full Text] [Related]
32. Tropolone antagonism of the L-dopa-induced elevation of S-adenosylhomocysteine: S-adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus.
Fuller RW; Perry KW; Hemrick-Leucke SK
J Pharm Pharmacol; 1984 Jun; 36(6):419-20. PubMed ID: 6146682
[TBL] [Abstract][Full Text] [Related]
33. Evidence for beta 2-adrenoceptor-mediated facilitation of 3H-noradrenaline release from isolated guinea pig papillary muscles.
Valenta B; Pittner H; Singer EA
J Cardiovasc Pharmacol; 1989 Dec; 14(6):846-50. PubMed ID: 2481771
[TBL] [Abstract][Full Text] [Related]
34. Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors.
Murugaiah KD; O'Donnell JM
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):483-90. PubMed ID: 7643911
[TBL] [Abstract][Full Text] [Related]
35. Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor.
McLaughlin DP; MacDonald A
Br J Pharmacol; 1991 Jun; 103(2):1351-6. PubMed ID: 1679358
[TBL] [Abstract][Full Text] [Related]
36. L-DOPA increases noradrenaline turnover in central and peripheral nervous systems.
Dayan L; Finberg JP
Neuropharmacology; 2003 Sep; 45(4):524-33. PubMed ID: 12907313
[TBL] [Abstract][Full Text] [Related]
37. Influence on turnover and level of hypothalamic noradrenaline by a new antihypertensive agent (GYKI 11679).
Huszti Z; Szilágyi G; Mátyus P; Kasztreiner E
J Neurochem; 1981 Nov; 37(5):1272-81. PubMed ID: 6117605
[TBL] [Abstract][Full Text] [Related]
38. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
Soares-da-Silva P; Pinto-do-O PC
Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
[TBL] [Abstract][Full Text] [Related]
39. Transmitter-like L-3,4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats.
Yue JL; Goshima Y; Misu Y
Neurosci Lett; 1993 Sep; 159(1-2):103-6. PubMed ID: 8264947
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the existence of stereoselective presynaptic beta 1-adrenoceptors on noradrenergic and dopaminergic neurons in the rat hypothalamus.
Chang CC; Goshima Y; Misu Y
Jpn J Pharmacol; 1986 Nov; 42(3):447-9. PubMed ID: 3029487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
